Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Broadwood Partners Now Owns 33.30% of OncoCyte (OCX)
Fintel reports that Broadwood Partners has filed a 13D/A form with the SEC disclosing ownership of 57.13MM shares of OncoCyte Corp (OCX). This represents 33.3%
GIC Private Now Owns 5.10% of Regenxbio (RGNX)
Fintel reports that GIC Private has filed a 13G form with the SEC disclosing ownership of 2.20MM shares of Regenxbio Inc (RGNX). This represents 5.1%
William Blair Investment Management Now Owns 11.00% of National Vision Holdings (EYE)
Fintel reports that William Blair Investment Management has filed a 13G/A form with the SEC disclosing ownership of 8.66MM shares of National Vision Holdings Inc
Gamco Investors, Inc. Et Al Now Owns 5.38% of INDUS Realty Trust, Inc. (INDT)
Fintel reports that Gamco Investors, Inc. Et Al has filed a 13D/A form with the SEC disclosing ownership of 0.55MM shares of INDUS Realty Trust,
Who Owns SpongeBob? AI Shakes Hollywood's Creative Foundation
Artificial-intelligence tools raise questions about intellectual property rights that are under scrutiny by courts and entertainment executives Source link
Orbimed Advisors Now Owns 11.20% of Gracell Biotechnologies (GRCL)
Fintel reports that Orbimed Advisors has filed a 13D form with the SEC disclosing ownership of 7.58MM shares of Gracell Biotechnologies Inc. (GRCL). This represents
Juniper Investment Company Now Owns 6.40% of Astro-Med (ALOT)
Fintel reports that Juniper Investment Company has filed a 13D/A form with the SEC disclosing ownership of 0.47MM shares of Astro-Med, Inc. (ALOT). This represents
Gen IV Investment Opportunities Now Owns 17.30% of Alphatec Holdings (ATEC)
Fintel reports that Gen IV Investment Opportunities has filed a 13D/A form with the SEC disclosing ownership of 2.94MM shares of Alphatec Holdings Inc (ATEC).
Why Warren Buffett Owns More of Apple, Bank of America, and Chevron Stocks Than You Might Think
Which stocks does Warren Buffett like the most? Obviously, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) deserves to be at the top of the list. Most
Ra Capital Management Now Owns 16.10% of DICE Therapeutics (DICE)
Fintel reports that Ra Capital Management has filed a 13D/A form with the SEC disclosing ownership of 7.66MM shares of DICE Therapeutics Inc (DICE). This